Privia Health Group, Inc. PRVA

Healthcare SIC 8000 - Services-Health Services Nasdaq

Privia Health Group, Inc. ("Privia Health", "we", "our", or the "Company") is a technology-driven, national physician-enablement company that collaborates with physician practices, health plans, and health systems to achieve the quadruple aim of better outcomes, lower costs, improved patient experience, and happier and more engaged providers. We seek to accomplish the quadruple aim by entering markets and organizing existing physicians and non-physician clinicians into a unique practice model that combines the advantages of a partnership in a large regional medical group (each, a "Medical Group") with significant provider autonomy for the physicians (collectively, "Privia Physicians") and non-physician clinicians (collectively "Privia Clinicians" and, together with the Privia Physicians, the "Privia Providers") in our Medical Groups.

Last close 20.66 2026-09-04
Market cap $2.64B 2026-06-30 share count
52-week range 19.53 - 28.82

Valuation FY2025 figures against the last close

P/S1.2x
P/E114.8x
P/FCF16.2x
EV/EBITDA59.8x
Dividend yield
Diluted EPS0.18

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $2.12B$1.74B$1.66B$1.36B$966.2M$817.1M$786.4M
SG&A $138.2M$126.2M$109.6M$129.6M$255.9M$44.0M$41.8M
Total operating expenses $2.09B$1.72B$1.64B$1.38B$1.18B$791.7M$770.3M
Operating income $34.2M$17.0M$20.6M-$19.1M-$217.4M$25.4M$16.1M
Interest expense $8.4M$542.0K$1.1M$1.9M$4.0M
Pre-tax income $43.9M$27.9M$29.0M-$18.6M-$218.5M$23.5M$9.2M
Income tax $14.2M$10.8M$8.0M$6.5M$27.9M$7.4M$1.2M
Net income $22.9M$14.4M$23.1M-$8.6M-$188.2M$31.2M$8.2M
EPS, basic 0.190.120.20-0.08-1.830.330.09
EPS, diluted 0.180.110.19-0.08-1.830.330.09
Shares, diluted (wtd. avg.) $128.9M$125.6M$124.7M$110.7M$103.0M$96.0M$95.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $479.7M$491.1M$389.5M$348.0M$320.6M$84.6M$46.9M$39.1M
Receivables $400.9M$316.2M$290.8M$189.6M$117.4M$99.1M
Total current assets $911.0M$834.8M$700.8M$552.0M$446.7M$190.1M
Property, plant and equipment $504.0K$1.2M$2.3M$3.4M$4.5M$4.8M
Goodwill $209.8M$141.6M$138.7M$126.9M$127.9M$118.7M
Other intangibles $215.9M$109.8M$107.6M$57.4M$59.7M$6.0M
Total assets $1.37B$1.14B$999.9M$792.8M$686.4M$329.0M
Accounts payable $8.0M$9.8M$7.9M$6.7M$3.0M$5.2M
Total current liabilities $568.5M$449.1M$387.0M$264.3M$190.5M$146.9M
Total liabilities $578.4M$452.3M$392.5M$273.8M$236.2M$185.3M
Retained earnings -$156.3M-$179.2M-$193.6M-$216.7M-$208.1M-$19.9M
Total equity $737.2M$635.2M$607.4M$519.0M$450.2M$143.7M$107.5M$86.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow $163.4M$109.3M$80.8M$47.2M$55.1M$38.9M$24.4M
Depreciation and amortisation $9.9M$7.3M$6.5M$4.6M$2.5M$1.8M$1.4M
Stock-based compensation $71.1M$56.7M$37.1M$67.4M$253.5M$484.0K$207.0K
Capital expenditure $113.0K$104.0K$547.0K$380.0K$5.7M
Investing cash flow -$181.6M-$12.0M-$43.0M-$104.0K-$32.8M-$380.0K-$5.7M
Financing cash flow $6.7M$4.3M$3.7M-$19.7M$213.7M-$767.0K-$10.9M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001759655-26-000010.

Others in SIC 8000

TickerCompanyMarket capP/ERevenue growth
LFST LifeStance Health Group, Inc. $4.86B 13.9%
WGS GeneDx Holdings Corp. $2.56B 40.0%
INNV InnovAge Holding Corp. $1.46B 11.8%
OMDA Omada Health, Inc. $1.39B 53.2%
PNTG Pennant Group, Inc. $1.33B 45.2x 36.3%
USPH U S PHYSICAL THERAPY INC /NV $1.18B 55.9x 16.3%
SRTA Strata Critical Medical, Inc. $470.6M 10.6x 34.3%
DCGO DocGo Inc. $39.8M -47.7%